Dr. Bilello- SBIR Grant Proposal Writer and Business Consultant
SBIR Grant Proposal Writer and Business Consultant Dr. Bilello is an expert in infectious and chronic diseases. He received his Ph.D. in Molecular Biology from Albert Einstein College of Medicine. His 17-year career in academic medicine began as an Instructor at the Johns Hopkins Oncology Center. Later, he rose from Assistant to Associate Professor in the departments of Microbiology and Neurology at the University of Maryland School of Medicine. His last academic post was at Albany Medical College, where he was an Associate Professor in the Departments of Medicine and Pharmacology. During this phase of his career, Dr. Bilello had developed an international reputation for innovative basic and clinical research on HIV and other retroviral diseases and their treatment.
Early in his career, he realized that great science does not automatically lead to adequate funding for research. High-quality science, innovation, and grantsmanship resulted in his becoming principal investigator of NSF Phase I and II SBIRs, as well as NIH contracts and research grants. While at the Veterans Administration Medical Center (VAMC) in Baltimore, Dr. Bilello was the principal investigator of multiple VA Merit Review Awards and the program grant, which established the Retrovirus Research Center at the VAMC. Dr. Bilello has also been a member of NIH Study Sections, reviewing SBIRs, RO1s, and contracts in the areas of technologies, devices, and therapeutics.
Dr. Bilello has over 25 years in the pharmaceutical industry, the biotechnology sector, as well as academic and government laboratories. Dr. Bilello joined GlaxoSmithKline (GSK), where he was the Director of Technology Development in Translational Medicine and Genetics. In his technology development role, Dr. Bilello assessed external technologies, identifying new investment opportunities for GSK’s Technology Investment Board. As a thought leader, he was part of a “Blue Sky” team that designed future scenarios for the pharmaceutical industry. His work with the Human Biomarker Laboratories led to tools for use in stratifying patients and monitoring efficacy in clinical studies. Specifically, he developed biomarkers for enabling studies of new therapeutics for COPD, diabetes/metabolic syndrome, migraine, and neurodegenerative diseases. Before joining GSK, he was a biochemist at Roche and the Director of Preclinical Research and Development at two successful biotechnology companies.
As an enthusiastic entrepreneur, Dr. Bilello was a founder and Chief Scientific Officer of a company which developed and commercialized a diagnostic for major depressive disorder. While there, he developed the intellectual property and is the inventor on nine U.S. and foreign patents. Dr. Bilello was also a co-founder and Managing partner of a consulting firm that aided life science companies to shape their business strategy, promote innovation, and accelerate commercial success. As a consultant to start-ups, spin-outs, and SMEs, he enables organizations to focus and to act wisely, with efficiency and agility. Working with Fortune 500 companies, he has mapped trends in molecular and multiplex protein diagnostics. As a seasoned SBIR grant proposal writer and business consultant with ScienceDocs, Dr. Bilello brings broad experience in drug development, diagnostics, acute and chronic diseases, and clinical pharmacology.
To work with SBIR Grant Proposal Writer and Business Consultant Dr. Bilello, please visit our quote page and request him in the description area.